---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-002359"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:30:47.724817+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals CFO Chad White resigns; Jerry Dvonch named interim CFO

## Summary
- Chad White resigned as CFO effective April 7, 2023; unvested options forfeited.
- Board appointed Jerry Dvonch (former CFO, Sept 2020–Nov 2022) as interim CFO.
- Dvonch to receive $250/hour plus $30,000 in restricted stock vesting July 15 and Aug 15, 2023.
- Consulting agreement runs until filing of Q1 FY2024 10-Q (quarter ending June 30, 2023).
- Dvonch's vested equity awards extended by one month per month of service under the agreement.

## SEC filing metadata
- accession: 0001683168-23-002359
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-002359
- JSON: https://secwatch.observer/filing/0001683168-23-002359.json
- Plain text: https://secwatch.observer/filing/0001683168-23-002359.txt

## Key facts
- Executive change
  Chad White resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm
- Executive change
  Jerry Dvonch was appointed as interim Chief Financial Officer at Sonoma Pharmaceuticals, Inc..
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: Effective April 7, 2023, Chad White resigned as our Chief Financial Officer, and our Board of Directors appointed Jerry Dvonch as our interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.